ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study-Reference-Cited by-同舟云学术

ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study

Published:2020-11-12 Issue:3 Volume:22 Page:175-179
ISSN:1558-2027
Container-title:Journal of Cardiovascular Medicine
language:en
Short-container-title:

Author:

D’Amario Domenico,Galli Mattia,Canonico Francesco,Restivo Attilio,Arcudi Alessandra,Scacciavillani Roberto,Cappannoli Luigi,Riccioni Maria Elena,Annetta Maria Giuseppina,Di Stefano Gaetano,Piccinni Carlo,Vergallo Rocco,Montone Rocco Antonio,Leone Antonio Maria,Niccoli Giampaolo,Sabatelli Mario,Antonelli Massimo,Andreotti Felicita,De Cristofaro Raimondo,Crea Filippo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference20 articles.

1. The 2018 European Heart Rhythm Association Practical Guide on the use of nonvitamin K antagonist oral anticoagulants in patients with atrial fibrillation;Steffel;Eur Heart J,2018

2. Relative bioavailability of apixaban solution or crushed tablet formulations administered by mouth or nasogastric tube in healthy subjects;Song;Clin Therap,2015

3. Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube;Moore;Clin Pharmacol Drug Dev,2014

4. Anticoagulation intensity of rivaroxaban for stroke patients at a special low dosage in Japan;Okata;PLoS One,2014

5. Sub therapeutic rivaroxaban plasma concentrations following administration via percutaneous endoscopic gastrostomy (PEG) feeding tubes: a note of caution;Byrne;Thromb Res,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigation;Minerva Cardiology and Angiology;2023-02

2. Feasibility, effectiveness, and safety of edoxaban administration through percutaneous endoscopic gastrostomy: 12-months follow up of the ORIGAMI study;Frontiers in Cardiovascular Medicine;2022-12-22

3. Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration?;Journal of the American College of Cardiology;2021-06